Gemphire Therapeutics Inc. 4
4 · Gemphire Therapeutics Inc. · Filed Mar 14, 2017
Insider Transaction Report
Form 4
LICHTINGER PEDRO
Director
Transactions
- Purchase
Common Stock
2017-03-10$9.47/sh+10,559$99,994→ 59,833 total - Purchase
Warrant to Purchase Common Stock
2017-03-10$9.47/sh+7,920$75,002→ 7,920 totalExercise: $10.40From: 2017-03-10Exp: 2022-03-15→ Common Stock (7,920 underlying)
Footnotes (1)
- [F1]The shares of common stock were purchased as part of a private placement pursuant to a Securities Purchase Agreement whereby the Issuer sold units consisting of one share of the Issuer's common stock and a warrant to purchase 0.75 shares of the Issuer's common stock at a per unit price of $9.47. The private placement is expected to close on March 15, 2017.